We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPLN:NYSEOPENLANE, Inc. analysis

Data as of Oct 13, 2026 - not real-time

Latest price
$37.49
Risk: medium
5/10Medium risk

Summary

OPENLANE, Inc. trades at $37.48, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 5.3% over the past 30 days. Momentum indicators put RSI at 65.1 (approaching overbought) with MACD reading bullish. The recent range runs from support at $33.85 up to resistance at $37.59.
The shares look fair at 21.6 times earnings, though no sector average was available for comparison. Consensus targets land 23.3% above where the shares trade now. Revenue is growing at 15.1% on a 9.7% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 23.6%, a beta of 0.87 and a maximum drawdown of 22.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.

Top market events

  • OPENLANE, Inc. NYSE: OPLN "OPENLANE" , today announced the launch of an underwritten secondary public offering of...
  • As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the business services &...
  • As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the business services &...

Market outlook

Short term

< 1 year

Positive

Model confidence5/105 out of 10

Key factors

  • Trading above the 200-day average of 33.69
  • MACD momentum is positive
  • 30-day price change of +5.3%

Medium term

1–3 years

Positive

Model confidence5/105 out of 10

Key factors

  • Trading above the 200-day average of 33.69
  • Analyst targets imply +23.3% versus the current price
  • MACD momentum is positive

Long term

> 3 years

Positive

Model confidence5/105 out of 10

Key factors

  • Analyst targets imply +23.3% versus the current price
  • Revenue growth of +15.1%
  • P/E ratio of 21.6

Key metrics

Financial health

Revenue Growth15.10%
Profit Margin9.67%
P/E Ratio21.6
ROE11.15%
ROA4.58%
Debt/Equity157.36
P/B Ratio2.9
Op. Cash Flow$410.1M
Free Cash Flow$26.4M

Technical analysis

TrendNeutral
RSI65.1
Support$33.85
Resistance$37.59
MA 20$35.08
MA 50$35.30
MA 200$33.69
MACDBullish
VolumeIncreasing
Fear & Greed Index94

Valuation

Target Price$46.22
Upside/Downside23.31%
GradeFair
TypeGrowth

Risk assessment

Beta0.87
Volatility23.56%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.